Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - NATIONAL RESEARCH CORPex_99846.htm
8-K - FORM 8-K - NATIONAL RESEARCH CORPnrci20171108_8k.htm

Exhibit 99.2

 

Mike:

 

Thank you, ___________, and welcome everyone to National Research Corporation’s 2017 third quarter earnings call. My name is Mike Hays, the Company’s CEO. Joining me on the call today is Kevin Karas, our Chief Financial Officer.

 

I would like to ask Kevin to review with us conditions regarding any forward looking statements that may be made as part of our call today.

 

Kevin.

 

Kevin:

 

Thank you, Mike.

 

This conference call includes forward-looking statements related to the Company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the Company's future results, please see the Company's filings with the Securities and Exchange Commission.

 

 

 

 

Mike.

 

Mike:

Thanks, and again, welcome everyone. For our call today Kevin has some prepared remarks regarding our third quarter and year-to-date 2017 performance. After which we will be going directly to any questions you may have – so please feel free to enter the question que as Kevin shares our financial performance highlights.

 

Kevin.

 

Kevin:

Thanks, Mike.

 

Total contract value at the end of the third quarter totaled $123.6 million, representing 7% growth over the same period last year. Healthcare system clients with agreements for multiple solutions represented 21% of our client base at the end of the third quarter 2017, up from 19% at the same time last year. Subscription-based revenue agreements at the end of the third quarter of 2017 represented 93% of the total recurring contract value.

 

2

 

 

Third quarter 2017 revenue was $29.0 million, an increase of 7% over the third quarter of 2016, and was comprised entirely of organic growth from adding new clients and increasing contract value for existing clients.

 

Consolidated operating income for the third quarter 2017 was $7.1 million or 25% of revenue, compared to $7.3 million, or 27% of revenue for the same period last year.

 

Total operating expenses increased by 11% to $21.8 million for the third quarter 2017, compared to $19.7 million for the same period last year.

 

Direct expenses increased 7% to $12.3 million for the third quarter 2017, up from $11.5 million for the same period in 2016. Direct expenses as a percent of revenue was consistent at 42% for the third quarter in both 2017 and 2016. Our variable direct expenses as a percent of revenue decreased compared to last year as incremental variable cost of product expenses from revenue growth in the quarter were offset by decreased expenses from changes in data collection methodologies. At the same time, our fixed direct expenses increased as additional resources were allocated for client services.

 

3

 

 

Selling, general and administrative expenses increased to $8.4 million for the third quarter 2017, compared to $7.1 million for the same period last year. SG&A expenses in 2017 included $975,000 of expenses associated with the proposed recapitalization. SG&A expenses were 29% of revenue for the third quarter of 2017 compared to 26% of revenue for the same period in 2016.

 

Depreciation and amortization expenses stayed consistent at $1.1 million for the third quarters in both 2017 and 2016.

 

The provision for income taxes totaled $3.0 million for the third quarter 2017, compared to $2.6 million for the same period in 2016. The effective tax rate was 42% for the third quarter 2017, compared to 35% for the same period in 2016. The increase in the effective rate was mainly due to $384,000 of additional tax expense from non-deductible expenses associated with the proposed recapitalization.

 

Net income for the third quarter was $4.2 million in 2017, compared to $4.7 million in 2016. Diluted earnings per share decreased to $0.09 for Class A shares and $0.57 for Class B shares for the quarter ended September 30, 2017, down from $0.11 for Class A shares and $0.66 for Class B shares for the quarter ended September 30, 2016.

 

With that I’ll turn the call back to Mike.

 

4

 

 

Mike:

 

Thank you, Kevin.

 

This completes our prepared remarks so I will now ask _______________, to open the call to questions.

 

Closing Statement – Mike:

 

Thank you for your time today. We look forward to reporting our progress next quarter. 

 

5